Document Detail


Methylprednisolone reduces the inflammatory response to cardiopulmonary bypass in neonatal piglets: timing of dose is important.
MedLine Citation:
PMID:  10047655     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Cardiopulmonary bypass produces an inflammatory response that can cause significant postoperative pulmonary dysfunction and total body edema. This study evaluates the efficacy of preoperative methylprednisolone administration in limiting this injury in neonates and compares the effect of giving methylprednisolone 8 hours before an operation to the common practice of adding methylprednisolone to the cardiopulmonary bypass circuit prime. METHODS: A control group of neonatal pigs (control; n = 6) received no preoperative medication. One experimental group (n = 6) received methylprednisolone sodium succinate (30 mg/kg) both 8 and 1.5 hours before the operation. A second experimental group received no preoperative treatment, but methylprednisolone (30 mg/kg) was added to the cardiopulmonary bypass circuit prime. All animals underwent cardiopulmonary bypass and 45 minutes of deep hypothermic circulatory arrest. Hemodynamic and pulmonary function data were acquired before cardiopulmonary bypass and at 30 and 60 minutes after bypass. RESULTS: In the control group, pulmonary compliance, alveolar-arterial gradient, and pulmonary vascular resistance were significantly impaired after bypass (P <.01 for each by analysis of variance). In the group that received methylprednisolone, compliance (P =.02), alveolar-arterial gradient (P =.0003), pulmonary vascular resistance (P =.007), and extracellular fluid accumulation (P =.003) were significantly better after bypass when compared with the control group. Results for the group that received no preoperative treatment fell between the control group and the group that received methylprednisolone. CONCLUSIONS: When given 8 hours and immediately before the operation, methylprednisolone improves pulmonary compliance after bypass, alveolar-arterial gradient, and pulmonary vascular resistance compared with no treatment. The addition of methylprednisolone to the cardiopulmonary bypass circuit prime is beneficial but inferior to preoperative administration.
Authors:
A J Lodge; P J Chai; C W Daggett; R M Ungerleider; J Jaggers
Related Documents :
803175 - Coronary artery perfusion.
8080375 - Use of carmeda-coated femoral-femoral bypass during repair of traumatic aortic pseudoan...
21963725 - Fever after percutaneous endovascular stent-graft in type b acute aortic dissection.
10475445 - Vascular clamp for hemostasis and stabilization during minimally invasive direct corona...
3355725 - Atrioventricular septal defect in prenatal life.
3223305 - Influence of renal denervation on vascular responsiveness of isolated rat intrarenal ar...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  117     ISSN:  0022-5223     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  1999 Mar 
Date Detail:
Created Date:  1999-03-18     Completed Date:  1999-03-18     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  515-22     Citation Subset:  AIM; IM    
Affiliation:
Department of Surgery, Duke University Medical Center, Durham, NC, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Animals, Newborn
Anti-Inflammatory Agents / administration & dosage*
Blood Pressure / drug effects
Cardiopulmonary Bypass / adverse effects*
Drug Administration Schedule
Lung Compliance / drug effects
Methylprednisolone / administration & dosage*
Oxygen / blood
Preoperative Care
Pulmonary Circulation / drug effects
Pulmonary Gas Exchange / drug effects
Swine
Systemic Inflammatory Response Syndrome / etiology,  prevention & control*
Vascular Resistance / drug effects
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 7782-44-7/Oxygen; 83-43-2/Methylprednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-term outcome of infants with single ventricle and total anomalous pulmonary venous connection.
Next Document:  Comparison of longevity, pacing, and sensing characteristics of steroid-eluting epicardial versus co...